Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis

Journal of the American College of Cardiology

Volumn 41, Issue 9, 2003, Pages 1496-1505

  Wijeysundera, Duminda N ^a   Beattie, W Scott ^a   Rao, Vivek ^a   Karski, Jacek ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DOPAMINE; GLYCERYL TRINITRATE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; VERAPAMIL;

ARTICLE; BLEEDING; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; EMBASE; FORWARD HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PACING; HEART SURGERY; HUMAN; HYPERTENSION; INOTROPISM; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEDLINE; META ANALYSIS; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME; VALVE SURGERY;

EID: 0038414659     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00191-8     Document Type: Article

References (73)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001.
2. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. JAMA 1997;277:715-21.
3. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
4. Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology. 1985;62:107-14.
5. Sarabu MR, McClung JA, Fass A, Reed GE. Early postoperative spasm in left internal mammary artery bypass grafts. Ann Thorac Surg 1987;44:199-200.
6. Talajic M, Papadatos D, Villemaire C, Nayebpour M, Nattel S. Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias: importance of use-dependent calcium channel-blocking properties. Circulation 1990;81:334-42.
7. Stanley TO, Mackensen GB, Grocott HP, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290-5.
8. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 1996;276:300-6.
9. Fisher M, Grotta J. New uses for calcium channel blockers: therapeutic implications. Drugs 1993;46:961-75.
10. Weightman WM, Gibbs NM, Sheminant MR, Whitford EG, Mahon BD, Newman MA. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. Anesth Analg 1999;88:286-91.
11. Slogoff S, Keats AS. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia? Anesthesiology 1988;68:676-80.
12. Chung F, Houston PL, Cheng D, et al. Calcium channel blockade does not offer adequate protection from perioperative myocardial ischemia. Anesthesiology. 1988;69:343-7.
13. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
14. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-900.
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
16. Shapira OM, Xu A, Vita JA, et al. Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator. J Thorac Cardiovasc Surg 1999;117:906-11.
17. Amano J, Suzuki A, Sunamori M, Tofukuji M. Effect of calcium antagonist diltiazem on renal function in open heart surgery. Chest 1995;107:1260-5.
18. Babin-Ebell J, Keith PR, Elert O. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1996;10:412-6.
19. Colson P, Medioni P, Saussine M, et al. Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery. J Cardiothorac Vasc Anesth 1992;6:424-8.
20. Davison R, Hartz R, Kaplan K, Parker M, Feiereisel P, Michaelis L. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial. Ann Thorac Surg 1985;39:336-9.
21. Donegani E, Costa P, De Paulis R, et al. Myocardial protection by perioperative diltiazem drip: a clinical evaluation. Thorac Cardiovasc Surg 1986;34:168-71.
22. Ferraris VA, Ferraris SP, Gilliam H, Berry W. Verapamil prophylaxis for postoperative atrial dysrhythmias: a prospective, randomized, double-blind study using drug level monitoring. Ann Thorac Surg 1987;43:530-3.
23. Hannes W, Fasol R, Zajonc H, et al. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting. Eur J Cardiothorac Surg 1993;7:239-45.
24. Hannes W, Seitelberger R, Christoph M, et al. Effect of peri-operative diltiazem on myocardial ischaemia and function in patients receiving mammary artery grafts. Eur Heart J 1995;16:87-93.
25. Hirnle T, Stachurski A, Negrusz-Kawecka M, Halawa B, Bross T. Myocardial protection during coronary artery by-pass surgery with nitroglycerin or diltiazem. Kardiol Pol 2000;52:277-84.
26. Keilich M, Kulinna C, Seitelberger R, Fasol R. Postoperative follow-up of coronary artery bypass patients receiving calcium antagonist diltiazem. Int J Angiol 1997;6:8-12.
27. Lassnigg A, Wutte M, Grubhofer G, et al. Diltiazem versus nitroglycerin for myocardial protection following coronary artery bypass grafting as assessed by dobutamine stress echocardiography. Wien Klin Wochenschr 2001;113:439-45.
28. Lischke V, Probst S, Behne M, Dietrich HA. Prevention of myocardial ischemia: study following aortocoronary bypass operation with the calcium antagonist diltiazem. Anaesthesist 1995;44:92-100.
29. Malhotra R, Mishra M, Kler TS, Kohli UM, Mehta Y, Trehan N. Cardioprotective effects of diltiazem infusion in the perioperative period. Eur J Cardiothorac Surg 1997;12:420-7.
30. Schoneberger A, Raschka C, Reifart N, Hoffmann S, Satter P. A comparative study of verapamil and propafenone in the prophylaxis of atrial fibrillation after cardiac surgery. Herz Kreislauf 1992;24:94-7.
31. Seitelberger R, Hannes W, Gleichauf M, et al. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg 1994;107:811-21.
32. Shapira OM, Alkon JD, Macron DS, et al. Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm. Ann Thorac Surg 2000;70:883-8.
33. Smith EE, Shore DF, Monro JL, Ross JK. Oral verapamil fails to prevent supraventricular tachycardia following coronary artery surgery. Int J Cardiol 1985;9:37-44.
34. Tschirkov A, Mishev B, Natschev G, Petkov R, Alexandro V, Jurukova Z. Perioperative myocardial protection with the calcium antagonist diltiazem. Eur J Cardiothorac Surg 1992;6:225-35.
35. Williams DB, Misbach GA, Kruse AP, Ivey TD. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. J Thoracic Cardiovasc Surg 1985;90:592-6.
36. Zanardo G, Michielon P, Rosi P, et al. Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vasc Anesth 1993;7:711-6.
37. Apostolidou IA, Despotis GJ Hogue CW Jr., et al. Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting. Ann Thorac Surg 1999;67:417-22.
38. Bertolissi M, Antonucci F, De Monte A, Padovani R, Giordano F. Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996;10:238-42.
39. Combes P, Durand M. Comparison of nicardipine and sodium nitroprusside in the treatment of hypertension after coronary bypass surgery. Acta Anaesthesiol Belg 1992;43:113-9.
40. David D, Dubois C, Loria Y. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. J Cardiothorac Vasc Anesth 1991;5:357-61.
41. Dupuis JY, Nathan HJ, Laganiere S. Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization. Can J Anaesth 1992;39:1012-22.
42. Fang W, Mao L. Pretreatment with nicardipine against myocardial damage in hypothermic extracorporeal circulation. Acta Acad Med Shanghai 1995;22:359-62.
43. Forsman M, Olsnes BT, Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth 1990;65:514-20.
44. Hicks GL Jr., Salley RK, DeWeese JA. Calcium channel blockers: an intraoperative and postoperative trial in women. Ann Thorac Surg 1984;37:319-23.
45. Knothe C, Boldt J, Zickmann B, et al. Cardiac protection in heart surgery interventions by preventive drug administration before extracorporeal circulation: studies with troponin T as a parameter for perioperative myocardial damage. Herz 1993;18:379-86.
46. Koolen JJ, van Wezel HB, Visser CA, et al. Nicardipine for preservation of myocardial metabolism and function in patients undergoing coronary artery surgery. Anesthesiology. 1989;71:508-18.
47. Legault C, Furberg CD, Wagenknecht LE, et al. Nimodipine neuro-protection in cardiac valve replacement: report of an early terminated trial. Stroke 1996;27:593-8.
48. Leslie J, Brister N, Levy JH, et al. Treatment of postoperative hypertension after coronary artery bypass surgery: double-blind comparison of intravenous isradipine and sodium nitroprusside. Circulation 1994;90 Suppl II:II256-61.
49. Nathan HJ, Laganiere S, Dube L, et al. Intravenous nifedipine to treat hypertension after coronary artery revascularization surgery: a comparison with sodium nitroprusside. Anesth Analg 1992;74:809-17.
50. Petry A, Wulf H, Blomer U, Wawersik J. Nifedipine versus nitroglycerin in aortocoronary bypass surgery: the effect on hemodynamics, kidney function and homologous blood requirement. Anaesthesist 1992;41:39-46.
51. Ruegg PC, David D, Loria Y. Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. Eur J Anaesthesiol 1992;9:293-305.
52. Seitelberger R, Zwolfer W, Binder TM, et al. Infusion of nifedipine after coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia. Ann Thorac Surg 1990;49:61-7.
53. Seitelberger R, Zwolfer W, Huber S, et al. Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting. Circulation 1991;83:460-8.
54. van Wezel HB, Koolen JJ, Visser CA, et al. The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension. J Cardiothorac Anesth 1989;3:700-6.
55. van Wezel HB, Koolen JJ, Visser CA, et al. Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting. Am J Cardiol 1989;64:22H-7H.
56. Donmez A, Ergun F, Kayhan Z, Tasdelen A, Dogan S. Verapamil and nimodipine do not improve renal function during cardiopulmonary bypass. Acta Anaesthesiol Ital 1998;49:173-7.
57. van Wezel HB, Bovill JG, Schuller J, Gielen J, Hoeneveld MH. Comparison of nitroglycerine, verapamil and nifedipine in the management of arterial pressure during coronary artery surgery. Br J Anaesth 1986;58:267-73.
58. Force T, Hibberd P, Weeks G, et al. Perioperative myocardial infarction after coronary artery bypass surgery: clinical significance and approach to risk stratification. Circulation 1990;82:903-12.
59. Jain U, Laflamme CJ, Aggarwal A, et al. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. Anesthesiology 1997;86:576-91.
60. Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994;71:633-40.
61. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;20:1402-5.
62. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
63. Vander Salm TJ, Kaur S, Lancey RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg 1996;112:1098-107.
64. Greet IA, Walker JJ, McLaren M, Calder AA, Forbes CD. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro. Thromb Res 1986;41:509-18.
65. Jones CR, Pasanisi F, Elliott HL, Reid JL. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. Br J Clin Pharmacol 1985;20:191-6.
66. Kiyomoto A, Sasaki Y, Odawara A, Morita T. Inhibition of platelet aggregation by diltiazem: comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites. Circ Res 1983;52 Suppl I:I-115-9.
67. Kizer JR, Kimmel SE. Epidemiologic review of the calcium channel blocker drugs: an up-to-date perspective on the proposed hazards. Arch Intern Med 2001;161:1145-58.
68. Guffin AV, Kates RA, Holbrook GW, Jones EL, Kaplan JA. Verapamil and myocardial preservation in patients undergoing coronary artery bypass surgery. Ann Thorac Surg 1986;41:587-91.
69. Christakis GT, Fremes SE, Weisel RD, et al. Diltiazem cardioplegia: a balance of risk and benefit. J Thorac Cardiovasc Surg 1986;91:647-61.
70. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13.
71. Clark HD, Wells GA, Huet C, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 1999;20:448-52.
72. Berlin JA. Does blinding of readers affect the results of meta-analyses? Lancet 1997;350:185-6.
73. Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993;269:2749-53.